Jane Street’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-190,404
Closed -$1.96M 11025
2024
Q4
$1.96M Buy
190,404
+149,133
+361% +$1.44M ﹤0.01% 4137
2024
Q3
$392K Sell
41,271
-20,829
-34% -$180K ﹤0.01% 7598
2024
Q2
$529K Buy
62,100
+24,092
+63% +$220K ﹤0.01% 6930
2024
Q1
$352K Buy
38,008
+20,348
+115% +$179K ﹤0.01% 7301
2023
Q4
$171K Buy
+17,660
New +$165K ﹤0.01% 8322
2023
Q2
Sell
-42,602
Closed -$447K 9744
2023
Q1
$447K Buy
+42,602
New +$469K ﹤0.01% 6508

Other funds holding ENFN

Jane Street's ENFN Position: Q1 2025 in Review

Jane Street sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 190,404 shares — an estimated $1.96M sold.

Jane Street first reported a position in ENFN in Q1 2023 and held it in 6 quarters. The position peaked at $1.96M in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Jane Street reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Jane Street sold 190,404 Enfusion, Inc. shares in Q1 2025, an estimated $1.96M.
  • Jane Street first reported a position in Enfusion, Inc. in Q1 2023 and held it in 6 quarters.
  • Jane Street's Enfusion, Inc. position peaked at $1.96M in Q4 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.